Cargando…

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

Uncertainty remains about how long the protective immune responses against severe acute respiratory syndrome coronavirus 2 persists, and suspected reinfection in recovered patients has been reported. We describe a case of reinfection from distinct virus lineages in Brazil harboring the E484K mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nonaka, Carolina K. V., Franco, Marília Miranda, Gräf, Tiago, de Lorenzo Barcia, Camila Araújo, de Ávila Mendonça, Renata Naves, de Sousa, Karoline Almeida Felix, Neiva, Leila M. C., Fosenca, Vagner, Mendes, Ana V. A., de Aguiar, Renato Santana, Giovanetti, Marta, de Freitas Souza, Bruno Solano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084516/ https://www.ncbi.nlm.nih.gov/pubmed/33605869 http://dx.doi.org/10.3201/eid2705.210191

Ejemplares similares

E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil
por: Ferrareze, Patrícia Aline Gröhs, et al.
Publicado: (2021)

SARS-CoV-2 Detection via RT-PCR in Matched Saliva and Nasopharyngeal Samples Reveals High Concordance in Different Commercial Assays
por: de Sousa, Karoline Almeida Felix, et al.
Publicado: (2023)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil
por: Resende, Paola Cristina, et al.
Publicado: (2021)

SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2021)

COVID-19: Is reinfection possible?
por: Costa, Aratã Oliveira Cortez, et al.
Publicado: (2021)

Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil
por: Fonseca, Vagner, et al.
Publicado: (2021)

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
por: Schröder, Simon, et al.
Publicado: (2023)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
por: Kolehmainen, Pekka, et al.
Publicado: (2023)

Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q
por: Ahamad, Shahzaib, et al.
Publicado: (2022)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

MON-484 Thyroid Nodules: Not so Simple to Manage
por: Cruz, Alegyari Figueroa, et al.
Publicado: (2020)

Emergence of OXA-484-Producing Klebsiella variicola in China
por: Ge, Haoyu, et al.
Publicado: (2023)

Detection of the B"-GWGR variant in the southernmost region of Brazil: unveiling the complexity of the human immunodeficiency virus-1 subtype B epidemic
por: Junqueira, Dennis Maletich, et al.
Publicado: (2013)

Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
por: Adrielle dos Santos, Letícia, et al.
Publicado: (2021)

SUN-484 Complex Thyroid Cancer with Several Recurrences and Metastases
por: Patel, Kruti K, et al.
Publicado: (2020)

miR-484: A Potential Biomarker in Health and Disease
por: Jia, Yin-zhao, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama
por: Díaz, Yamilka, et al.
Publicado: (2021)

A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan
por: Sekizuka, Tsuyoshi, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody
por: Chakraborty, Sandipan
Publicado: (2022)

Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
por: Halfmann, Peter J, et al.
Publicado: (2022)

Factors associated with reinfection of syphilis in reference centers for sexually transmitted infections
por: de Almeida, Valéria Correa, et al.
Publicado: (2017)

SARS-CoV-2 reinfection: report of two cases in Southeast Brazil
por: Yu, Ana Lucia Frugis, et al.
Publicado: (2021)

The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
por: Racine, Étienne, et al.
Publicado: (2022)

Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic
por: Junqueira, Dennis Maletich, et al.
Publicado: (2016)

435. Outcomes for E484K Mutation Negative COVID-19 Patients Cohorted with E484K Mutation Positive COVID-19 Patients: A Retrospective Cohort Study
por: Buskandar, Fahad, et al.
Publicado: (2021)

A Genomic Approach to Resolving Relapse versus Reinfection among Four Cases of Buruli Ulcer
por: Eddyani, Miriam, et al.
Publicado: (2015)

Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
por: Colson, Philippe, et al.
Publicado: (2022)

The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice
por: Hu, Longbo, et al.
Publicado: (2022)

COVID-19 Reinfection
por: Habadi, Mohammed I, et al.
Publicado: (2021)

miR-484 is associated with disease recurrence and promotes migration in prostate cancer
por: Lee, Daniel, et al.
Publicado: (2020)

Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil
por: de Siqueira, Isadora Cristina, et al.
Publicado: (2021)

De novo emergence of the mutation E484K in a SARS-CoV-2 B.1.1.7 lineage variant()
por: Urrutikoetxea-Gutierrez, Mikel, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2021)

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
por: Schuler, Charles F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19cuq64fnd2fpedbmen3vm0qdh